COVID-19 will cause acute strain on medical affairs in the short term, but longer-term planning is also needed to ensure that teams can remain in the more visible role that customers are demanding, writes Sarah Jarvis.
Sarah Jarvis
Advertisement
Sarah Jarvis is a principal at ZS and global lead on medical affairs consulting.
Articles by Sarah Jarvis
Advertisement
Latest Updated Articles
- How Medical Affairs Teams Need to Adapt to COVID-19
Published: March 30th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Alkermes plc Acquiring Avadel Pharmaceuticals in $2.1 Billion Definitive Agreement
3
Novo Nordisk Stock Reacts to Recent Board Changes
4
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
5
